Core Viewpoint - The company plans to issue H shares and apply for listing on the Hong Kong Stock Exchange to enhance its global strategy and brand recognition [1][2]. Group 1: Company Actions - The company convened its second board meeting and supervisory board meeting on August 7, 2025, where it approved the proposal for issuing H shares and listing on the Hong Kong Stock Exchange [1]. - The issuance aims to accelerate the company's global expansion and improve its overseas business capabilities [1]. Group 2: Regulatory Compliance - The issuance and listing are subject to approval from the company's shareholders and must comply with various legal requirements, including those from the China Securities Regulatory Commission and the Hong Kong Stock Exchange [2]. - The company is currently discussing the specifics of the issuance with relevant intermediaries, but details have not yet been finalized [2].
可孚医疗: 关于筹划发行H股股票并在香港联合交易所有限公司上市的提示性公告